Medical Devices

With a $15M boost, a tech veteran's personal health crisis fuels a mission to revolutionize blood pressure monitoring for millions worldwide.

A landmark program merges AI health monitoring and on-site doctors, allowing pilgrims with chronic conditions to safely perform Umrah for the first time.

SERB Pharma's acquisition of Idefirix® rights offers new hope to thousands of highly sensitized patients previously unable to receive a kidney transplant.

With backing from Bain Capital and Armistice, the life sciences firm's latest offering aims to fund its push to automate pharmaceutical quality control.

A Minnesota jury found major companies liable for a man's terminal cancer from asbestos in talc powders, highlighting a growing legal battle.

Mineralys Therapeutics' lorundrostat shows promise for millions with uncontrolled blood pressure and kidney disease, targeting a key hormonal driver.

Born from a major merger, the new Pure Infusion brand seeks to transform ambulatory care with a 'patient-obsessed' model and a vast national network.

EyePromise launches Heyedrate Clinical, a new artificial tear with European-proven tech, promising longer relief for millions suffering from dry eye.

A new state-of-the-art facility in South Carolina promises to accelerate medical innovation by ensuring the next generation of devices is safer for patients.

Quince Therapeutics' drug LAM-001 posts strong Phase 2a data, showing meaningful functional gains for patients with severe pulmonary hypertension.

Unilog.SC CEO Osi Tagger's 'Executive of the Year' award signals a new era of tech-driven, human-led logistics in a world of constant disruption.

A new partnership with AI firm Basepath Health will help Children's Mercy treat five times more children with complex and rare genetic diseases.

A new bispecific antibody, TRIV-573, enters clinical trials, targeting both skin barrier and inflammation to redefine atopic dermatitis therapy.

Beyond fat removal, a new wave of cosmetic surgery in Dubai uses advanced tech to craft athletic, natural bodies, making the city a global beauty hub.

With a new CEO who led a startup to FDA approval and acquisition, VahatiCor aims to commercialize its novel A-FLUX system for millions with chronic chest pain.

Industry veteran Steve Motes joins Tulyp Medical as CEO, aiming to commercialize a revolutionary pressure-driven perfusion system with a proven team.

Las Vegas surgeon Dr. Kornelis Poelstra has completed 2,000 robotic spine procedures, a milestone that highlights a revolution in surgical precision.

Glucotrack seeks FDA trial approval for its revolutionary 3-year implantable glucose monitor, racing against financial clocks to change diabetes care.

Amid major Medicare policy shifts, Nuo Therapeutics reports a 169% revenue surge, positioning its Aurix wound care system as a key market disruptor.

The biotech firm is set to launch its first commercial products, using an innovative strategy to tackle long-neglected markets in women's healthcare.